HEXPOL (HPOL) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
21 Dec, 2025Executive summary
Q1 2025 sales reached 5,381 MSEK, up 1% year-over-year, with stable sales in Europe and the U.S. and improvement in Asia, especially in Engineered Products.
EBIT was 839 MSEK, down from 905 MSEK last year, with an EBIT margin of 15.6% versus 17.0%.
Cash flow improved to 188 MSEK from 112 MSEK in Q1 2024, despite typical seasonal softness.
Organizational changes were made to drive growth, including merging thermoplastics and TPE into one product area and integrating high-performance compounds into rubber compounding.
Kabkom acquisition in Turkey strengthens position in wire and cable compounds; almaak minority share in Germany also acquired.
Financial highlights
Sales: 5,381 MSEK (Q1'24: 5,312 MSEK), up 1% year-over-year; organic sales down 3%, offset by 3% growth from Piedmont acquisition.
Adjusted EBIT of 839 MSEK, down 7% year-over-year, with margin at 15.6% (vs. 17% last year).
Profit after tax: 602 MSEK (Q1'24: 654 MSEK); EPS: SEK 1.75 (Q1'24: SEK 1.90).
Net debt increased to 2,346 MSEK, with net debt/EBITDA at 0.63 (Q1'24: 0.36), reflecting recent acquisitions.
Equity/assets ratio at 62% (Q1'24: 66%); return on capital employed (R12) at 16.6% (Q1'24: 18.8%).
Outlook and guidance
No material impact from U.S. tariffs in Q1, but direct and indirect effects expected in the U.S. due to raw material prices.
Active mitigation includes alternative suppliers and price negotiations; margin protection expected to remain robust.
M&A remains a focus, with a positive long-term view despite current market uncertainty.
Capital Markets Day scheduled for November 4, 2025, in Stockholm.
Latest events from HEXPOL
- 2030 targets: >10% EPS CAGR, 14-16% EBIT margin, and accelerated M&A in Thermoplastics.HPOL
CMD 202511 Mar 2026 - Q4 saw lower sales and margins from FX and mix, but volumes and cash flow improved.HPOL
Q4 20253 Feb 2026 - Sales fell but margins rose, supporting a strong outlook and continued M&A focus.HPOL
Q2 20243 Feb 2026 - Sales and profit declined 9% year-over-year, but margins and cash flow stayed strong.HPOL
Q3 202418 Jan 2026 - Sales and profit declined, but cash flow and margins remained strong amid efficiency actions.HPOL
Q4 20249 Jan 2026 - Q3 sales and EBIT declined, but strong cash flow and acquisitions supported resilience.HPOL
Q3 202524 Oct 2025 - Sales and profit declined, but Engineered Products and cash flow improved.HPOL
Q2 202518 Jul 2025